6/27/24 20:00 | 6/26/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S | -20 | 4.75 | 0 | -4 | -6 | 60 | D | | | | | | | | | | | | | | |
6/3/24 20:00 | 5/31/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S | -11 | 6.09 | 0 | -2 | -3 | 64 | D | | | | | | | | | | | | | | |
1/5/24 16:04 | 1/4/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S.d | -8 | 6.74 | 0 | -1 | -2 | 66 | D | | | | | | | | | | | | | | |
1/6/23 20:00 | 1/4/23 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S | -2 | 28.54 | 0 | 0 | -1 | 12 | D | | | | | | | | | | | | | | |
10/28/22 16:15 | 10/26/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S | -1 | 6.51 | 0 | 0 | -7 | 2 | D | | | | | | | | | | | | | | |
6/29/22 20:12 | 6/27/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S | -1 | 0.3700 | 0 | -3 | -2 | 131 | D | | | | | | | | | | | | | | |
1/5/22 20:00 | 1/4/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S.d | -4 | 1.30 | 0 | -3 | -2 | 133 | D | | | | | | | | | | | | | | |
10/28/21 20:04 | 10/26/21 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S | -17 | 1.80 | 0 | -9 | -6 | 136 | D | | | | | | | | | | | | | | |
6/29/21 17:26 | 6/28/21 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | S | -14 | 5.77 | 0 | -2 | -2 | 146 | D | | | | | | | | | | | | | | |
6/11/20 16:58 | 6/9/20 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | M.d | 115 | 2.64 | 0 | 43 | 903 | 48 | D | | | | | | | | | | | | | | |